Rivastigmine is a carbamate-derived reversible cholinesterase inhibitor that is selective for the central nervous system and is used for the treatment of dementia in alzheimer disease and parkinson disease. Rivastigmine is a cholinesterase inhibitor. The mechanism of action of rivastigmine is as a cholinesterase inhibitor.